BCWORLD PHARM. Co., Ltd. (200780.KQ)
KRW 4810.0
(0.73%)
KRW 4810.0
(0.73%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 75.11 Billion | 72.7 Billion | 62.07 Billion | 57.03 Billion | 51.49 Billion | 54.79 Billion |
| Cost of Revenue | 46.51 Billion | 48.51 Billion | 42.86 Billion | 40.71 Billion | 34.76 Billion | 33.74 Billion |
| Gross Profit | 28.59 Billion | 24.18 Billion | 19.21 Billion | 16.31 Billion | 16.73 Billion | 21.05 Billion |
| Operating Expenses | 25.59 Billion | 22.32 Billion | 20.74 Billion | 17.76 Billion | 17.73 Billion | 15.44 Billion |
| Selling, General and Administrative Expenses | 8.58 Billion | 14.71 Billion | 11.87 Billion | 7.11 Billion | 9.84 Billion | 8.7 Billion |
| Research and Development Expenses | 1.19 Billion | 7.55 Billion | 8.66 Billion | 10.43 Billion | 7.75 Billion | 6.72 Billion |
| Other Expenses | 15.81 Billion | -58.83 Million | -200.34 Million | -219.58 Million | -141.94 Million | -24.84 Million |
| Cost and Expenses | 68.74 Billion | 70.84 Billion | 63.61 Billion | 58.47 Billion | 52.5 Billion | 49.19 Billion |
| Operating Income | 6.36 Billion | 1.86 Billion | -1.53 Billion | -1.44 Billion | -1 Billion | 5.6 Billion |
| Interest Expense | 5.23 Billion | 3.79 Billion | 2.16 Billion | 2.41 Billion | 2.37 Billion | 234.03 Million |
| Income Tax Expense | -1.68 Billion | -1.58 Billion | 42.05 Million | -635.65 Million | -833.04 Million | 520.35 Million |
| Earnings before Tax | 1.2 Billion | -1.52 Billion | -2.93 Billion | -2.82 Billion | -2.57 Billion | 5.48 Billion |
| Net Income | 2.63 Billion | 281.29 Million | -1.84 Billion | -1.57 Billion | -1.55 Billion | 4.99 Billion |
| Earnings Per Share Basic | 312.11 | 33.01 | -215.85 | -185.68 | -183.57 | 590.22 |
| Earnings Per Share Diluted | 312.11 | 33.01 | -215.85 | -185.68 | -183.57 | 590.22 |
| Weighted Average Shares Outstanding | 8.43 Million | 8.52 Million | 8.53 Million | 8.5 Million | 8.45 Million | 8.45 Million |
| Weighted Average Shares Outstanding (Diluted) | 8.43 Million | 8.52 Million | 8.53 Million | 8.5 Million | 8.45 Million | 8.45 Million |
| Gross Margin | 0.38 | 0.33 | 0.31 | 0.29 | 0.32 | 0.38 |
| EBIT Margin | 0.19 | 0.13 | 0.07 | 0.05 | 0.05 | 0.16 |
| Profit Margin | 0.04 | 0.00 | -0.03 | -0.03 | -0.03 | 0.09 |
| EBITDA | 14.13 Billion | 9.53 Billion | 4.81 Billion | 4.12 Billion | 2.43 Billion | 9.11 Billion |
| Earnings Before Tax Margin | 0.08 | 0.03 | -0.02 | -0.03 | -0.02 | 0.10 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 19.46 Billion | 16.3 Billion | 19.59 Billion | 75.11 Billion | 17.59 Billion | 18.69 Billion |
| Cost of Revenue | 14.23 Billion | 10.42 Billion | 12.56 Billion | 46.51 Billion | 11.55 Billion | 10.79 Billion |
| Gross Profit | 5.22 Billion | 5.88 Billion | 7.03 Billion | 28.59 Billion | 6.04 Billion | 7.89 Billion |
| Operating Expenses | 5.54 Billion | 6.36 Billion | 6.13 Billion | 22.23 Billion | 5.26 Billion | 4.83 Billion |
| Selling, General and Administrative Expenses | 3.7 Billion | 4.47 Billion | 4.44 Billion | - | 3.96 Billion | 3.77 Billion |
| Research and Development Expenses | 1.74 Billion | 1.82 Billion | 1.6 Billion | - | 1.24 Billion | 1.05 Billion |
| Other Expenses | -91.08 Million | -59.83 Million | -80.52 Million | -132.23 Million | -51.66 Million | -49.66 Thousand |
| Cost and Expenses | 19.77 Billion | 16.78 Billion | 18.69 Billion | 68.74 Billion | 16.81 Billion | 15.63 Billion |
| Operating Income | -316.33 Million | -482.26 Million | 897.61 Million | 6.36 Billion | 781.25 Million | 3.06 Billion |
| Interest Expense | 1.2 Billion | 1.25 Billion | 1.32 Billion | 5.23 Billion | 1.26 Billion | 1.25 Billion |
| Income Tax Expense | 472.74 Million | -71.97 Million | 2.96 Billion | -1.68 Billion | -542.08 Million | -4.46 Billion |
| Earnings before Tax | -1.28 Billion | -1.62 Billion | -206.4 Million | 1.2 Billion | -472.06 Million | 1.4 Billion |
| Net Income | -1.94 Billion | -1.54 Billion | -3.49 Billion | 2.63 Billion | 87.3 Million | 5.81 Billion |
| Earnings Per Share Basic | -229.98 | -183.61 | -414.06 | - | 10.35 | 689.16 |
| Earnings Per Share Diluted | -229.98 | -183.61 | -414.06 | - | 10.35 | 689.16 |
| Weighted Average Shares Outstanding | 8.43 Million | 8.43 Million | 8.43 Million | 8.43 Million | 8.43 Million | 8.43 Million |
| Weighted Average Shares Outstanding (Diluted) | 8.43 Million | 8.43 Million | 8.43 Million | 8.43 Million | 8.43 Million | 8.43 Million |
| Gross Margin | 0.27 | 0.36 | 0.36 | 0.38 | 0.34 | 0.42 |
| EBIT Margin | 0.08 | 0.09 | 0.15 | - | 0.15 | 0.27 |
| Profit Margin | -0.10 | -0.10 | -0.18 | 0.04 | 0.00 | 0.31 |
| EBITDA | 1.6 Billion | 1.42 Billion | 2.98 Billion | - | 2.67 Billion | 4.95 Billion |
| Earnings Before Tax Margin | -0.02 | -0.03 | 0.05 | 0.08 | 0.04 | 0.16 |
BLA
9922
MMSI
ESSENTIA
GRR
0240